Pharmaceutical
Consolidated Financial Results for the Three Months Ended April 30, 2026[Japanese GAAP]
Consolidated Financial Results for the Three Months Ended April 30, 2026[Japanese GAAP]
![Consolidated Financial Results for the Three Months Ended April 30, 2026[Japanese GAAP]](https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d62211beedb30cb6fc300c.webp)
About this update from Sanbio Co., Ltd.
Sanbio Co., Ltd. (4592) Press ReleaseView Attachment